Last reviewed · How we verify
NCT04718532
A New Technique For Retinal Disease Treatment
trial in Retina Disorder in 2,000 participants. Status unknown.
1 January 2023
Quick facts
| Lead sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 January 2016 |
| Primary completion | 1 January 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across China |
Conditions studied
- Retina Disorder — all drugs for Retina Disorder →
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Who can join
Eligibility, any sex, with Retina Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With the advent of the era of precision medicine, based on FFA image deep learning to identify the area of fundus lesions, registration of fundus images, according to the severity of fundus diseases to design the optimal laser energy and path, the accurate treatment of fundus diseases has urgent clinical needs and very important significance
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
FIVES: A Fundus Image Dataset for Artificial Intelligence based Vessel Segmentation.
Jin K, Huang X, Zhou J, Li Y, et al · · 2022 · cited 76× · PMID 35927290 · DOI 10.1038/s41597-022-01564-3 -
iERM: An Interpretable Deep Learning System to Classify Epiretinal Membrane for Different Optical Coherence Tomography Devices: A Multi-Center Analysis.
Jin K, Yan Y, Wang S, Yang C, et al · · 2023 · cited 23× · PMID 36675327 · DOI 10.3390/jcm12020400 -
GRAPE: A multi-modal dataset of longitudinal follow-up visual field and fundus images for glaucoma management.
Huang X, Kong X, Shen Z, Ouyang J, et al · · 2023 · cited 19× · PMID 37543686 · DOI 10.1038/s41597-023-02424-4 -
A Structure-Related Fine-Grained Deep Learning System With Diversity Data for Universal Glaucoma Visual Field Grading.
Huang X, Jin K, Zhu J, Xue Y, et al · · 2022 · cited 15× · PMID 35372429 · DOI 10.3389/fmed.2022.832920 -
Clinical evaluation of deep learning systems for assisting in the diagnosis of the epiretinal membrane grade in general ophthalmologists.
Yan Y, Huang X, Jiang X, Gao Z, et al · · 2024 · cited 7× · PMID 37848677 · DOI 10.1038/s41433-023-02765-9 -
Diabetic Retinopathy Assessment through Multitask Learning Approach on Heterogeneous Fundus Image Datasets.
Wu H, Jin K, Jing Y, Shen W, et al · · 2025 · cited 2× · PMID 40520476 · DOI 10.1016/j.xops.2025.100755 -
Segmentation of Low-Light Optical Coherence Tomography Angiography Images under the Constraints of Vascular Network Topology.
Li Z, Huang G, Zou B, Chen W, et al · · 2024 · cited 1× · PMID 38339491 · DOI 10.3390/s24030774
Verify or expand the search:
- PubMed search for NCT04718532
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials
Trials by the same sponsor.
- NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
- NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
- NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
- NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
- NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04718532 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
- Last refreshed: 22 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04718532.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing